[go: up one dir, main page]

PE20060214A1 - Preparaciones topicas que contienen ambroxol - Google Patents

Preparaciones topicas que contienen ambroxol

Info

Publication number
PE20060214A1
PE20060214A1 PE2005000488A PE2005000488A PE20060214A1 PE 20060214 A1 PE20060214 A1 PE 20060214A1 PE 2005000488 A PE2005000488 A PE 2005000488A PE 2005000488 A PE2005000488 A PE 2005000488A PE 20060214 A1 PE20060214 A1 PE 20060214A1
Authority
PE
Peru
Prior art keywords
voclamo
hydrophyl
itching
cream
containing ambroxol
Prior art date
Application number
PE2005000488A
Other languages
English (en)
Inventor
Anke Esperester
Frieder Ulrich Maerz
Claudia Mueller
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966914&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20060214(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20060214A1 publication Critical patent/PE20060214A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA TOPICA SELECCIONADA ENTRE SUPOSITORIOS, PASTAS HIDROFOBAS, POMADAS, CREMAS, LOCIONES Y LAPICES QUE CONTIENE HIDROCLORURO DE AMBROXOL O UNA DE SUS SALES FARMACOLOGICAMENTE ACEPTABLES CUYO CONTENIDO VARIA ENTRE 0,1% Y 20%. DICHA COMPOSICION POSEE EFICACIA ANTIINFLAMATORIA Y ANESTESICA SATISFACTORIA QUE AL SER EXTENDIDAS O APLICADAS DIRECTAMENTE SOBRE LAS PIEL Y/O MUCOSAS PROPORCIONA UN EFECTO PROLONGADO EN COMPARACION CON LA CREMA HIDROFILA NO IONICA SIENDO UTILES EN EL TRATAMIENTO TOPICO DE INFLAMACIONES DOLOROSAS O PRURIGINOSAS EN LA BOCA Y VAGINA, PICADURAS DE MOSQUITOS, ERITEMAS CUTANEOS DE ORIGEN ALERGICO, INMUNOLOGICO O IDIOPATICO Y HEMORROIDES CON PRURITO Y ESCOZOR
PE2005000488A 2004-05-03 2005-04-29 Preparaciones topicas que contienen ambroxol PE20060214A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004021992A DE102004021992A1 (de) 2004-05-03 2004-05-03 Topische Zubereitung enthaltend Ambroxol

Publications (1)

Publication Number Publication Date
PE20060214A1 true PE20060214A1 (es) 2006-04-26

Family

ID=34966914

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000488A PE20060214A1 (es) 2004-05-03 2005-04-29 Preparaciones topicas que contienen ambroxol

Country Status (21)

Country Link
US (1) US20050266058A1 (es)
EP (1) EP1744738A1 (es)
JP (1) JP2007536296A (es)
KR (1) KR20070005020A (es)
CN (1) CN1950076A (es)
AR (1) AR049036A1 (es)
AU (1) AU2005239809A1 (es)
BR (1) BRPI0510600A (es)
CA (1) CA2565183A1 (es)
DE (1) DE102004021992A1 (es)
EC (1) ECSP066970A (es)
IL (1) IL178975A0 (es)
MD (1) MD4093B1 (es)
MX (1) MXPA06012655A (es)
PE (1) PE20060214A1 (es)
RU (1) RU2381794C2 (es)
SG (1) SG152257A1 (es)
TW (1) TW200603787A (es)
UA (1) UA87841C2 (es)
WO (1) WO2005107732A1 (es)
ZA (1) ZA200608017B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012005986A2 (pt) * 2009-09-18 2015-09-08 Procter & Gamble substrato que compreende uma composição de loção que limita a aderência de fezes ou menstruação à pele.
EP2637635A1 (de) * 2010-11-12 2013-09-18 La Prairie Group AG Kosmetische und/oder dermatologische zubereitungen enthaltend schneealgenextrakt
BR112013012815A2 (pt) * 2010-12-23 2016-09-13 Lectio Pharmaentwicklungs Und Verwertungs Gmbh solução aquosa de ambroxol
PH12013501896A1 (en) * 2011-03-14 2013-10-14 Boehringer Ingelheim Int Use of a sprayable composition comprising ambroxol
JP5954676B2 (ja) * 2011-03-21 2016-07-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アンブロキソールを含む固体製剤
RU2513514C1 (ru) * 2012-11-23 2014-04-20 Общество с ограниченной ответственностью "НПК "Трифарма" Фармацевтическая композиция, содержащая налбуфина гидрохлорид, ее применение для лечения болевого синдрома средней и высокой интенсивности и способ получения фармацевтической композиции
WO2015125757A1 (ja) * 2014-02-18 2015-08-27 大正製薬株式会社 内服液剤
AU2015261940B2 (en) * 2014-05-23 2020-07-09 A. Nattermann & Cie. Gesellschaft mit Beshränkter Haftung Cough medicine containing ambroxol hydrochloride
ES2988280T3 (es) 2016-11-14 2024-11-19 Neuvision Dev Llc Formulaciones y métodos relacionados para el tratamiento de enfermedades de la superficie ocular
EP3654960A1 (en) 2017-07-16 2020-05-27 Neuere, LLC Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity
JP7077582B2 (ja) * 2017-11-13 2022-05-31 京セラドキュメントソリューションズ株式会社 現像剤補給装置およびそれを備えた画像形成装置
JP7369716B2 (ja) 2018-01-26 2023-10-26 ノイレ， エルエルシー 皮膚バリア機能を改善するためのアンブロキソールの使用
WO2020030991A1 (en) * 2018-08-09 2020-02-13 Nal Pharmaceutical Group Limited Dosage form for insertion into the mouth
CN113995721A (zh) * 2020-07-27 2022-02-01 德国吉麦医疗技术有限公司 一种盐酸氨溴索口腔喷雾溶液及其制备方法
CN112168782A (zh) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 一种呼吸系统药物口服喷雾剂的制备方法
CN112168783A (zh) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 一种呼吸系统药物口服喷雾剂及制备方法
CN118021768A (zh) * 2022-11-14 2024-05-14 上海云晟研新生物科技有限公司 氨溴索口溶膜组合物、其制备方法及应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
DE3610997A1 (de) * 1986-04-02 1987-10-15 Krewel Werke Gmbh Ambroxol-nasenspray
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
KR930011993B1 (ko) * 1991-12-23 1993-12-23 주식회사 럭키 지속성-방출형 약학적 조성물 및 그 제조방법
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
JP4983750B2 (ja) * 1997-01-17 2012-07-25 大正製薬株式会社 経口投与用製剤
JPH10259130A (ja) * 1997-01-17 1998-09-29 Taisho Pharmaceut Co Ltd 経口投与用製剤
JP2000007561A (ja) * 1998-06-18 2000-01-11 Nissho Corp 塩酸アンブロキソール水溶液製剤
KR100638150B1 (ko) * 1998-12-23 2006-10-26 이데아 악티엔게젤샤프트 생체내에서 국부적인 비침습성 용도로 사용되는 개선된 제제
DE19933148A1 (de) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
US20030216423A1 (en) * 2000-05-24 2003-11-20 Sergio Ulloa Stable liquid and solid formulations
KR20030045473A (ko) * 2001-12-04 2003-06-11 대신제약주식회사 점막부착성을 가지는 의약품 조성물
JP2009235093A (ja) * 2001-12-21 2009-10-15 Daiichi Sankyo Healthcare Co Ltd 鼻炎用医薬組成物
US20030171391A1 (en) * 2002-01-25 2003-09-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of chronic pain
DE10203104A1 (de) * 2002-01-25 2003-08-07 Boehringer Ingelheim Pharma Ambroxol für die Behandlung chronischer Schmerzen
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
DE10332473A1 (de) * 2003-07-16 2005-02-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von Epilepsie
DE10332487A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
CN1546008A (zh) * 2003-12-02 2004-11-17 沈阳药科大学 盐酸氨溴索液体缓释制剂及其制备方法
CN1628645A (zh) * 2003-12-15 2005-06-22 南京金鹰医药科技开发有限公司 盐酸氨溴索口腔崩解片及其制备方法
CN1602848A (zh) * 2004-08-23 2005-04-06 南昌弘益科技有限公司 盐酸氨索溴滴丸及其制备方法
CN1299673C (zh) * 2004-10-01 2007-02-14 耿燕 盐酸氨溴索滴丸及其制备方法
CN1650868A (zh) * 2004-12-02 2005-08-10 四川川投医药生物技术有限责任公司 一种治疗肺部感染性疾病的复方药物制剂及其制备方法
CN1839802A (zh) * 2006-01-27 2006-10-04 无锡山禾药业股份有限公司 一种盐酸氨溴索口腔崩解片及其制备方法
CN1820755A (zh) * 2006-04-03 2006-08-23 陈旭良 头孢呋辛/盐酸氨溴索的药物组合
CN1843372A (zh) * 2006-05-11 2006-10-11 陈旭良 氨溴索与两种抗菌药物分别组成的药物组合
CN101099730A (zh) * 2006-07-03 2008-01-09 天津康鸿医药科技发展有限公司 含盐酸氨溴索与愈创木酚甘油醚活性成分的口服固体制剂
CN101084912A (zh) * 2007-07-02 2007-12-12 山东省医药工业研究所 复方盐酸氨溴索缓释片及其制备方法
JP5337405B2 (ja) * 2007-09-17 2013-11-06 ザ・ホスピタル・フォー・シック・チルドレン ゴーシェ病の治療方法
CN101480382A (zh) * 2008-01-09 2009-07-15 大百汇生物科技（深圳）有限公司 一种治疗急慢性鼻窦炎的药物组合物及其制备方法
CN101352417A (zh) * 2008-08-29 2009-01-28 扬州市三药制药有限公司 盐酸氨溴索口服溶液及其制备方法
CN101590043A (zh) * 2009-07-03 2009-12-02 北京华禧联合科技发展有限公司 一种治疗呼吸道感染的复方制剂及其制备方法

Also Published As

Publication number Publication date
ECSP066970A (es) 2006-12-29
BRPI0510600A (pt) 2007-10-30
ZA200608017B (en) 2008-07-30
JP2007536296A (ja) 2007-12-13
AU2005239809A1 (en) 2005-11-17
MXPA06012655A (es) 2007-01-16
CN1950076A (zh) 2007-04-18
KR20070005020A (ko) 2007-01-09
IL178975A0 (en) 2007-03-08
DE102004021992A1 (de) 2005-11-24
RU2006142735A (ru) 2008-06-20
US20050266058A1 (en) 2005-12-01
TW200603787A (en) 2006-02-01
RU2381794C2 (ru) 2010-02-20
CA2565183A1 (en) 2005-11-17
AR049036A1 (es) 2006-06-21
UA87841C2 (ru) 2009-08-25
WO2005107732A1 (de) 2005-11-17
EP1744738A1 (de) 2007-01-24
SG152257A1 (en) 2009-05-29
MD4093B1 (ro) 2011-02-28

Similar Documents

Publication Publication Date Title
PE20060214A1 (es) Preparaciones topicas que contienen ambroxol
ES2553742T3 (es) Forma de dosificación farmacéutica que comprende 6'-fluor-(N-metil- o N,N-dimetil)-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina
PT1227820E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
CR20110131A (es) Derivados de prostaglandinas
RU2350333C3 (ru) Применение ивермектина для лечения дерматологических расстройств
CL2015002899A1 (es) Composición farmacéutica de ungüento topico estable y excipiente adecuado seleccionado a partir de cera blanca, parafina blanda blanca y mezclas de los mismos. (divisional de solicitud 848-2011).
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
WO2001041550A3 (en) Topical anesthetic formulation
US20080076831A1 (en) Hemorrhoid reliever and method of use
PT1414467E (pt) Tratamento topico da mastalgia
AR055453A1 (es) Uso de la idebenona en una composicion destinada a ser aplicada sobre la piel y composicion que la comprende
GT200300249A (es) Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua
KR890009400A (ko) 다이클로닌 Hcl및 페놀을 함유하는 약제학적 조성물
MA31678B1 (fr) Composition therapeutique aromatisee a base d'argile
AR057413A1 (es) Polvo desintegrable oralmente que comprende cilostazol
KR940701249A (ko) 진통제
FR3034662B1 (fr) Nouvelles utilisations du peptide de sequence his-d-trp-ala-trp-d-phe-lys-nh2 pour diminuer ou retarder l'apparition de la senescence cellulaire et des signes du vieillissement cutane
PE20050359A1 (es) Composiciones topicas que comprenden terbinafina e hidrocortisona
AR036834A1 (es) Inhibicion viral por n-docosanol.
CO5251413A1 (es) Uso nuevo
CL2008002730A1 (es) Composicion farmaceutica dermatologica, de aplicacion topica, en forma de crema, gel, unguento, solucion, emulsion que comprende 1a 99% de pentoxifilina, 0,1 a 80% de crema base y 0,1 a 75% de liposomas, util para rosacea, trastornos con fotosensibil
TR202009156A2 (tr) Yara iyileşmesini ve iltihabın azalmasını destekleyici bitkisel takviye kremi
AR029829A1 (es) Uso de un derivado de la caseina para la preparacion de composiciones cosmeticas, farmaceuticas y veterinarias y las composiciones asi preparadas, utiles para inhibir la adhesion de la flora patogenica a la piel
MA28467B1 (fr) Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
TH99615A (th) อนุพันธ์พรอสทาแกลนดิน

Legal Events

Date Code Title Description
FC Refusal